AZD-9056, a P2X7 receptor inhibitor, suppresses ATP-induced melanogenesis

J Dermatol Sci. 2020 Dec;100(3):227-229. doi: 10.1016/j.jdermsci.2020.09.008. Epub 2020 Sep 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / pharmacology
  • Adenosine Triphosphate / metabolism*
  • Benzamides / pharmacology*
  • Cells, Cultured
  • Humans
  • Melanins / analysis
  • Melanins / biosynthesis*
  • Microphthalmia-Associated Transcription Factor / metabolism
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Monophenol Monooxygenase / metabolism
  • Primary Cell Culture
  • Purinergic P2X Receptor Antagonists / pharmacology*
  • Receptors, Purinergic P2X7 / metabolism
  • Skin Pigmentation / drug effects*
  • Skin Pigmentation / physiology
  • gp100 Melanoma Antigen / metabolism

Substances

  • AZD9056
  • Benzamides
  • MITF protein, human
  • Melanins
  • Microphthalmia-Associated Transcription Factor
  • P2RX7 protein, human
  • Purinergic P2X Receptor Antagonists
  • Receptors, Purinergic P2X7
  • gp100 Melanoma Antigen
  • Adenosine Triphosphate
  • Monophenol Monooxygenase
  • Adamantane